Full Event Guide
- 19+ claudin industry speakers, including Astellas, AstraZeneca, Bolt BioTherapeutics, Innovent Biologics, Altentis Therapeutics, Triumvira Immunologics and Transcenta, across 2 jam-packed conference days spanning preclinical, translational, and clinical development
- Exclusive opening conference presentations from Astellas and Xencor showcasing the cutting-edge therapeutic development across Zolbertuximab and further claudin therapies revolutionizing oncology treatments
- Unlock claudin therapy development insights representing all therapeutic modalities across monoclonal antibodies, bispecifics, ADCs and cell therapies, with content covering CLDN18.2, CLDN6, CLDN1 and beyond
- 7+ hours of dedicated networking time with interactive online functionalities across online delegate profiles, roundtable discussions, networking chat rooms, live speaker Q&As, and speed networking to strengthen and forge long-term, mutually beneficial relationships
